Insider Transactions in Q4 2022 at Viracta Therapeutics, Inc. (VIRX)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 28
2022
|
Daniel R. Chevallard CFO and COO |
SELL
Open market or private sale
|
Direct |
3,532
-3.96%
|
$7,064
$2.72 P/Share
|
|
Nov 28
2022
|
Lisa Rojkjaer Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,116
-4.39%
|
$4,232
$2.72 P/Share
|
|
Nov 25
2022
|
Daniel R. Chevallard CFO and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
6,889
+7.16%
|
-
|
|
Nov 25
2022
|
Ivor Royston |
BUY
Exercise of conversion of derivative security
|
Direct |
25,219
+3.8%
|
-
|
|
Nov 25
2022
|
Roger Pomerantz |
BUY
Exercise of conversion of derivative security
|
Direct |
9,034
+14.29%
|
-
|
|
Nov 25
2022
|
Lisa Rojkjaer Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,127
+7.88%
|
-
|